WINLEVI (clascoterone)
TOPICAL ANTIANDROGENS · ACNE VULGARIS
SUN PHARMA GLOB
Drug class
Topical Antiandrogens
Topical antiandrogens are a therapeutic class of locally applied agents designed to inhibit androgenic signaling within cutaneous tissues, such as sebaceous glands and hair follicles. Read more about Topical Antiandrogens
1 drugs in this class 1 manufacturers
Drugs in Topical Antiandrogens
Filter & compare in the drug finder →
Opens the drug finder with Topical Antiandrogens preselected. Add indication or manufacturer filters there.
Topical antiandrogens are a therapeutic class of locally applied agents designed to inhibit androgenic signaling within cutaneous tissues, such as sebaceous glands and hair follicles.
They exert their therapeutic effect primarily by competitively blocking androgen receptors—preventing dihydrotestosterone and testosterone binding—which diminishes local sebum production and reduces follicular inflammation.
By acting directly within the skin and rapidly metabolizing into inactive forms, these agents provide targeted hormonal modulation while minimizing systemic endocrine exposure and side effects.
The class is established for the management of acne vulgaris, exemplified by the androgen receptor inhibitor clascoterone, and is under clinical investigation for androgenetic alopecia.
-
nih.gov
Topical antiandrogens are a therapeutic class of locally applied agents designed to inhibit androgenic signaling within cutaneous tissues, such as sebaceous glands and hair follicles They exert their therapeutic effect primarily by competitively blocking androgen receptors—preventing dihydrotestosterone and testosterone binding—which diminishes local sebum production and reduces follicular inflammation By acting directly within the skin and rapidly metabolizing into inactive forms, these agents ...
-
mdpi.com
Topical antiandrogens are a therapeutic class of locally applied agents designed to inhibit androgenic signaling within cutaneous tissues, such as sebaceous glands and hair follicles The class is established for the management of acne vulgaris, exemplified by the androgen receptor inhibitor clascoterone, and is under clinical investigation for androgenetic alopecia
-
nih.gov
They exert their therapeutic effect primarily by competitively blocking androgen receptors—preventing dihydrotestosterone and testosterone binding—which diminishes local sebum production and reduces follicular inflammation
-
nih.gov
By acting directly within the skin and rapidly metabolizing into inactive forms, these agents provide targeted hormonal modulation while minimizing systemic endocrine exposure and side effects
-
nih.gov
The class is established for the management of acne vulgaris, exemplified by the androgen receptor inhibitor clascoterone, and is under clinical investigation for androgenetic alopecia
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.